Evidence map›Paper›PMID 35274943›Full record

ReviewJournal of chemical information and modeling2022

Identifying Novel Inhibitors for Hepatic Organic Anion Transporting Polypeptides by Machine Learning-Based Virtual Screening.

Alzbeta Tuerkova, Brandon J Bongers, Ulf Norinder, Orsolya Ungvári, Virág Székely, Andrey Tarnovskiy, Gergely Szakács, Csilla Özvegy-Laczka, Gerard J P van Westen, Barbara Zdrazil

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of chemical information and modeling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Virtual screening: hope, hype, and the fine line in between.Expert opinion on drug discovery · 2025
    Review
  4. Article
  5. Review
  6. Pharmaceutical science advances · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 5 countries.

Alzbeta TuerkovaDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.
Brandon J BongersDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.
Ulf NorinderDepartment of Pharmaceutical Biosciences, Uppsala University, Box 591, SE-75124 Uppsala, Sweden.ORCID 0000-0003-3107-331X
Orsolya UngváriDrug Resistance Research Group, Institute of Enzymology, RCNS, Eötvös Loránd Research Network, Magyar tudósok krt. 2, H-1117 Budapest, Hungary.
Virág SzékelyDrug Resistance Research Group, Institute of Enzymology, RCNS, Eötvös Loránd Research Network, Magyar tudósok krt. 2, H-1117 Budapest, Hungary.
Andrey TarnovskiyEnamine Ltd., 78 Chervonotkatska Street, 02094 Kyiv, Ukraine.
Gergely SzakácsDrug Resistance Research Group, Institute of Enzymology, RCNS, Eötvös Loránd Research Network, Magyar tudósok krt. 2, H-1117 Budapest, Hungary.
Csilla Özvegy-LaczkaDrug Resistance Research Group, Institute of Enzymology, RCNS, Eötvös Loránd Research Network, Magyar tudósok krt. 2, H-1117 Budapest, Hungary.
Gerard J P van WestenDivision of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.ORCID 0000-0003-0717-1817
Barbara ZdrazilDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090 Vienna, Austria.ORCID 0000-0001-9395-1515
Institute of Molecular Life Sciences · HULeiden University · NLUniversity of Vienna · ATComprehensive Cancer Center Vienna · ATEnamine (Ukraine) · UAEötvös Loránd University · HUUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integration of statistical learning methods with structure-based modeling approaches is a contemporary strategy to identify novel lead compounds in drug discovery. Hepatic organic anion transporting polypeptides (OATP1B1, OATP1B3, and OATP2B1) are classical off-targets, and it is well recognized that their ability to interfere with a wide range of chemically unrelated drugs, environmental chemicals, or food additives can lead to unwanted adverse effects like liver toxicity and drug-drug or drug-food interactions. Therefore, the identification of novel (tool) compounds for hepatic OATPs by virtual screening approaches and subsequent experimental validation is a major asset for elucidating structure-function relationships of (related) transporters: they enhance our understanding about molecular determinants and structural aspects of hepatic OATPs driving ligand binding and selectivity. In the present study, we performed a consensus virtual screening approach by using different types of machine learning models (proteochemometric models, conformal prediction models, and XGBoost models for hepatic OATPs), followed by molecular docking of preselected hits using previously established structural models for hepatic OATPs. Screening the diverse

Indexed as

Organic Anion TransportersBiological TransportDrug InteractionsLigandsLiverLiver-Specific Organic Anion Transporter 1Membrane Transport ProteinsMolecular Docking SimulationPeptidesSolute Carrier Organic Anion Transporter Family Member 1B3LigandsLiver-Specific Organic Anion Transporter 1Membrane Transport ProteinsOrganic Anion TransportersPeptidesSolute Carrier Organic Anion Transporter Family Member 1B3

Identifiers

PMID35274943
PMCPMC9795544
OpenAlexW4220791160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.